CSS
UNCY icon

Cubist Systematic Strategies’s Unicycive Therapeutics UNCY Stock Holding History

Cubist Systematic Strategies’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$104K Buy
+23,947
New +$104K ﹤0.01% 2770

Other funds holding UNCY

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's UNCY Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Unicycive Therapeutics (UNCY) in Q3 2025: 23,947 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #2770 among its holdings.

30 funds tracked by Wall St. Rank hold UNCY as of Q3 2025.

  • Cubist Systematic Strategies held 23,947 shares of Unicycive Therapeutics worth $104K as of Q3 2025.
  • Unicycive Therapeutics was a new Cubist Systematic Strategies position in Q3 2025.
  • Unicycive Therapeutics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2770 holding.
  • 30 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.